Chokkalingam A. Risk of total non-hepatic cancer following treatment for HCV infection with direct-acting antiviral agents. PS-155.
HBsAg-verlies na staken nucleo(s)tide-analogen afhankelijk van HBV-genotype en antigeenniveaus
okt 2022 | Hepatitis, Hepatologie, Virale infecties